News
Sun Pharmaceutical Industries Limited announced Leqselvi (deuruxolitinib) 8 mg tablets is now available to healthcare providers and people living with severe alopecia areata in the US. Leqselvi is ...
Leqselvi (deuruxolitinib) 8 mg tablets are approved for adults with severe alopecia areata, a disease that causes the immune system to attack hair follicles, leading to partial or complete hair loss ...
The 23-year-old actress, who announced the birth of her child in January, shared her experience with the common condition.
While humans can regularly replace certain cells, like those in our blood and gut, we cannot naturally regrow most other ...
JOYA Health, which bills itself as the first employee skin benefit platform, has signed with local employers IRA Capital and ...
Zebrafish can regenerate sensory hair cells that humans permanently lose, like those in the inner ear linked to hearing and balance. New research reveals two specific genes that control how different ...
Wearing a hat may contribute to hair loss and temporary or permanent balding due to factors such as tension or infection of ...
Weight loss injections can help people lose more weight than with other methods of weight loss, including lifestyle changes ...
India's top drugmaker by revenue Sun Pharma on Monday launched its anti-baldness drug Leqselvi in the U.S., following the ...
Sun Pharma and Incyte Corporation have settled a legal dispute over Leqselvi, a drug used for severe hair loss. Sun has ...
Sun Pharmaceutical Industries has reached a settlement with Incyte Corporation regarding the Leqselvi drug, used for severe ...
If you or a loved one ever experienced hair loss after cancer treatment, this Monday Morning Makeover might hit home.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results